tradingkey.logo

Servier to buy Day One Biopharmaceuticals for total equity value of $2.5 billion

ReutersMar 6, 2026 1:34 PM

- Independent international pharmaceutical group Servier will buy Day One Biopharmaceuticals DAWN.O for a total equity value of about $2.5 billion, the companies said on Friday.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI